STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

30.07.2014 18:14

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Correction of the release dated April 30, 2014

Hermann Leistner, Germany, notified us pursuant to sec. 21 para 1 of the German Securities Trading Act (WpHG) that his share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15, 20 and 25% on April 27, 2014 and amounted to 25.79% on this date (3,035,456 voting rights). Of these, 9.69% (1,140,000 voting rights) are attributable to him via Herdor GmbH & Co. KG and Herdor Beteiligungs GmbH pursuant to sec. 22 para 1 sentence 1 no. 1 of the German Securities Trading Act (WpHG). A further 15.72% (1,850,000 voting rights) are attributable to him via Tanja van Dinter, Bettina Siegle, and Ralf Leistner pursuant to sec. 22 para 2 of the German Securities Trading Act (WpHG).

Correction of the release dated April 30, 2014

Doris Leistner, Germany, notified us pursuant to sec. 21 para 1 of the German Securities Trading Act (WpHG) that her share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15, 20 and 25% on April 27, 2014 and amounted to 25.74% on this date (3,030,235 voting rights). Of these, 9.69% (1,140,000 voting rights) are attributable to her via Herdor GmbH & Co. KG and Herdor Beteiligungs GmbH pursuant to sec. 22 para 1 sentence 1 no. 1 of the German Securities Trading Act (WpHG). A further 15.72% (1,850,000 voting rights) are attributable to her via Tanja van Dinter, Bettina Siegle, and Ralf Leistner pursuant to sec. 22 para 2 of the German Securities Trading Act (WpHG).

Correction of the release dated April 30, 2014 and May 7, 2014
Herdor Beteiligungs GmbH, Unterschleissheim, Germany, notified us pursuant to sec. 21 para 1 of the German Securities Trading Act (WpHG) that its share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 10, 15, 20 and 25% on April 27, 2014 and amounted to 25.40% on this date (2,990,000 voting rights). Of these, 9.69% (1,140,000 voting rights) are attributable to it via Herdor GmbH & Co. KG pursuant to sec. 22 para 1 sentence 1 no. 1 of the German Securities Trading Act (WpHG). A further 15.72% (1,850,000 voting rights) are attributable to it via Tanja van Dinter, Bettina Siegle, and Ralf Leistner pursuant to sec. 22 para 2 of the German Securities Trading Act (WpHG).


30.07.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back